Carlson College of Veterinary Medicine

S. Mukherjee, Petrofsky, M., Yaraei, K., Bermudez, L. E., and Cangelosi, G. A., “The white morphotype of Mycobacterium avium-intracellulare is common in infected humans and virulent in infection models.”, The Journal of infectious diseases, vol. 184, no. 11, pp. 1480-4, 2001.

L. Danelishvili, Chinison, J. J. J., Pham, T., Gupta, R., and Bermudez, L. E., “The Voltage-Dependent Anion Channels (VDAC) of Mycobacterium avium phagosome are associated with bacterial survival and lipid export in macrophages.”, Sci Rep, vol. 7, no. 1, p. 7007, 2017.

N. Mohagheghpour, Bermudez, L. E., Khajavi, S., and Rivas, A., “The VLA-4/VCAM-1 molecules participate in gamma delta cell interaction with endothelial cells.”, Cellular immunology, vol. 143, no. 1, pp. 170-82, 1992.

L. Danelishvili, Cirillo, S. L. G., Cirillo, J. D., and Bermudez, L. E., “Virulent mycobacteria and the many aspects of macrophage uptake.”, Future microbiology, vol. 2, no. 5, pp. 461-4, 2007.

L. Danelishvili, Cirillo, S. L. G., Cirillo, J. D., and Bermudez, L. E., “Virulent mycobacteria and the many aspects of macrophage uptake.”, Future Microbiol, vol. 2, no. 5, pp. 461-4, 2007.

S. S. Jha, Danelishvili, L., Wagner, D., Maser, J., Li, Y. -jun, Moric, I., Vogt, S., Yamazaki, Y., Lai, B., and Bermudez, L. E., “Virulence-related Mycobacterium avium subsp hominissuis MAV_2928 gene is associated with vacuole remodeling in macrophages.”, BMC microbiology, vol. 10, p. 100, 2010.

S. S. Jha, Danelishvili, L., Wagner, D., Maser, J., Li, Y. -jun, Moric, I., Vogt, S., Yamazaki, Y., Lai, B., and Bermudez, L. E., “Virulence-related Mycobacterium avium subsp hominissuis MAV_2928 gene is associated with vacuole remodeling in macrophages.”, BMC Microbiol, vol. 10, p. 100, 2010.

L. E. Bermudez, “The use of monoclonal antibodies in the diagnosis of partially treated Pseudomonas aeruginosa meningitis: patient report.”, Brazilian journal of medical and biological research = Revista brasileira de pesquisas médicas e biológicas / Sociedade Brasileira de Biofísica .. [et al.], vol. 19, no. 2, pp. 159-65, 1986.

L. E. Bermudez, “[Use of monoclonal antibodies in the diagnosis and treatment of infection in immunocompromised patients].”, Revista paulista de medicina, vol. 105, no. 6, pp. 341-6, 1987.

L. E. Bermudez, “Use of liposome preparation to treat mycobacterial infections.”, Immunobiology, vol. 191, no. 4-5, pp. 578-83, 1994.

F. J. Sangari, Goodman, J. R., and Bermudez, L. E., “Ultrastructural study of Mycobacterium avium infection of HT-29 human intestinal epithelial cells.”, Journal of medical microbiology, vol. 49, no. 2, pp. 139-47, 2000.

L. E. Bermudez and Young, L. S., “Tumor necrosis factor alpha stimulates mycobactericidal/mycobacteriostatic activity in human macrophages by a protein kinase C-independent pathway.”, Cellular immunology, vol. 144, no. 2, pp. 258-68, 1992.

L. E. Bermudez and Young, L. S., “Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex.”, Journal of immunology (Baltimore, Md. : 1950), vol. 140, no. 9, pp. 3006-13, 1988.

L. E. Bermudez, Petrofsky, M., and Stevens, P., “Treatment with recombinant granulocyte colony-stimulating factor (Filgrastin) stimulates neutrophils and tissue macrophages and induces an effective non-specific response against Mycobacterium avium in mice.”, Immunology, vol. 94, no. 3, pp. 297-303, 1998.

L. E. Bermudez, Stevens, P., Kolonoski, P., Wu, M., and Young, L. S., “Treatment of experimental disseminated Mycobacterium avium complex infection in mice with recombinant IL-2 and tumor necrosis factor.”, Journal of immunology (Baltimore, Md. : 1950), vol. 143, no. 9, pp. 2996-3000, 1989.

L. E. Bermudez, Yau-Young, A. O., Lin, J. P., Cogger, J., and Young, L. S., “Treatment of disseminated Mycobacterium avium complex infection of beige mice with liposome-encapsulated aminoglycosides.”, The Journal of infectious diseases, vol. 161, no. 6, pp. 1262-8, 1990.

R. B. Cope, Stang, B. V., Valentine, B. A., and Bermudez, L. E., “Topical exposure to exogenous ultraviolet-irradiated urocanic acid enhances Mycobacterium ulcerans infection in a Crl:IAF(HA)-hrBR hairless guinea-pig model of Buruli ulcer disease.”, Photodermatology, photoimmunology & photomedicine, vol. 20, no. 1, pp. 14-20, 2004.

L. E. Bermudez, Reynolds, R., Kolonoski, P., Aralar, P., Inderlied, C. B., and Young, L. S., “Thiosemicarbazole (thiacetazone-like) compound with activity against Mycobacterium avium in mice.”, Antimicrobial agents and chemotherapy, vol. 47, no. 8, pp. 2685-7, 2003.

L. E. Bermudez, Inderlied, C. B., Kolonoski, P., Wu, M., Aralar, P., and Young, L. S., “Telithromycin is active against Mycobacterium avium in mice despite lacking significant activity in standard in vitro and macrophage assays and is associated with low frequency of resistance during treatment.”, Antimicrobial agents and chemotherapy, vol. 45, no. 8, pp. 2210-4, 2001.

M. McNamara, Tzeng, S. - C., Maier, C., Wu, M., and Bermudez, L. E., “Surface-exposed proteins of pathogenic mycobacteria and the role of cu-zn superoxide dismutase in macrophages and neutrophil survival.”, Proteome science, vol. 11, no. 1, p. 45, 2013.

M. McNamara, Tzeng, S. - C., Maier, C., Zhang, L., and Bermudez, L. E., “Surface proteome of "Mycobacterium avium subsp. hominissuis" during the early stages of macrophage infection.”, Infection and immunity, vol. 80, no. 5, pp. 1868-80, 2012.

G. Carter, Young, L. S., and Bermudez, L. E., “A subinhibitory concentration of clarithromycin inhibits Mycobacterium avium biofilm formation.”, Antimicrobial agents and chemotherapy, vol. 48, no. 12, pp. 4907-10, 2004.

L. E. Bermudez, Inderlied, C., and Young, L. S., “Stimulation with cytokines enhances penetration of azithromycin into human macrophages.”, Antimicrobial agents and chemotherapy, vol. 35, no. 12, pp. 2625-9, 1991.

L. E. Bermudez, Kolonoski, P., Seitz, L. E., Petrofsky, M., Reynolds, R., Wu, M., and Young, L. S., “SRI-286, a thiosemicarbazole, in combination with mefloquine and moxifloxacin for treatment of murine Mycobacterium avium complex disease.”, Antimicrobial agents and chemotherapy, vol. 48, no. 9, pp. 3556-8, 2004.

M. J. Harriff, Wu, M., Kent, M. L., and Bermudez, L. E., “Species of environmental mycobacteria differ in their abilities to grow in human, mouse, and carp macrophages and with regard to the presence of mycobacterial virulence genes, as observed by DNA microarray hybridization.”, Applied and environmental microbiology, vol. 74, no. 1, pp. 275-85, 2008.